Author:
Skelly Erin,Tognolini Delaney
Abstract
The SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2) pandemic revealed many flaws in our health care system. This review aims to explore the significance of loss to follow-up on patients with type 1 diabetes during the pandemic, the morbidity and mortality associated, and strategies to prevent loss to follow-up or to re-engage patients in longitudinal care.
[
Pediatr Ann
. 2024;53(7):e254–e257.]